89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 88 filers reported holding 89BIO INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,093,133 | -19.9% | 136,471 | +16.3% | 0.00% | 0.0% |
Q1 2024 | $1,365,430 | +17.2% | 117,305 | +12.5% | 0.00% | 0.0% |
Q4 2023 | $1,164,875 | -42.9% | 104,286 | -21.1% | 0.00% | -50.0% |
Q3 2023 | $2,039,701 | -30.8% | 132,105 | -15.1% | 0.00% | -20.0% |
Q2 2023 | $2,947,256 | +77.6% | 155,528 | +42.7% | 0.01% | +66.7% |
Q1 2023 | $1,659,552 | +26.8% | 108,966 | +6.0% | 0.00% | 0.0% |
Q4 2022 | $1,308,351 | +41.0% | 102,777 | -35.8% | 0.00% | +50.0% |
Q3 2022 | $928,000 | – | 160,194 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empery Asset Management, LP | 400,000 | $1,288,000 | 6.98% |
TCG Crossover Management, LLC | 1,133,196 | $3,649,000 | 1.55% |
GREAT POINT PARTNERS LLC | 1,400,000 | $4,508,000 | 1.08% |
DAFNA Capital Management LLC | 766,774 | $2,469,000 | 0.67% |
RA Capital Management | 7,782,669 | $25,060,000 | 0.67% |
BVF INC/IL | 3,898,000 | $12,552,000 | 0.61% |
Boxer Capital, LLC | 1,400,000 | $4,508,000 | 0.29% |
Orbimed Advisors | 3,658,869 | $11,782,000 | 0.21% |
Newtyn Management, LLC | 310,000 | $998,000 | 0.19% |
Orchard Capital Management, LLC | 168,493 | $592,000 | 0.18% |